Napo Pharmaceuticals
Crofelemer
A proprietary gastro-intestinal compound in clinical development for four distinct product indications
 |
 |
 |
|
||
 |
|
 |
|
||
news
April 20, 2010
Napo Enters Finder's Agreement for Development of Crofelemer in China
Napo Enters Finder's Agreement for Development of Crofelemer in China
October 26, 2009
Napo Acquires Rights to Additional CFTR Technology
Napo Acquires Rights to Additional CFTR Technology
October 8, 2009
Napo Gathers International Panel on Global Health
Napo Gathers International Panel on Global Health
August 4, 2009
Napo Pharmaceuticals Completes Dose Selection Phase of ADVENT Trial
Napo Pharmaceuticals Completes Dose Selection Phase of ADVENT Trial
May 31, 2009
KRON 4 - Napo Pharmaceuticals, Inc. Interview
KRON 4 - Napo Pharmaceuticals, Inc. Interview
May 27, 2009
Napo Participation in Call to Action to Prevent Deaths from Diarrheal Diseases in Children Under Five Years of Age
Napo Participation in Call to Action to Prevent Deaths from Diarrheal Diseases in Children Under Five Years of Age
May 19, 2009
Napo Pharmaceuticals, Inc. Appoints New Vice-President of Business Development
Napo Pharmaceuticals, Inc. Appoints New Vice-President of Business Development
May 5, 2009
Napo Pharmaceuticals Initiates Preclinical Development of a Novel CFTR Inhibitor Using Preclinical Resources Offered by the National Institute of Allergy and Infectious Diseases (NIAID)
Napo Pharmaceuticals Initiates Preclinical Development of a Novel CFTR Inhibitor Using Preclinical Resources Offered by the National Institute of Allergy and Infectious Diseases (NIAID)
April 30, 2009
Napo Pharmaceuticals Receives Biotech Humanitarian Award Nomination
Napo Pharmaceuticals Receives Biotech Humanitarian Award Nomination